HARVARD BIOSCIENCE INC Income Statement
HBIO|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$94M
FY2025
Gross Profit
$55M
58.2% gross margin
Operating Income
-$6M
FY2025
Net Income
-$12M
FY2025
HARVARD BIOSCIENCE INC reported $94M in revenue and $12M in net loss for FY2025. Revenue has grown at a 0.7% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94.1M | $112.3M | $113.3M | $118.9M | $102.1M | $116.2M | $120.8M | $77.4M | $108.7M | $108.7M | $105.2M | $111.2M | $108.9M | $108.2M | $85.8M |
| Cost of Revenue | $39.4M | $46.2M | $52.5M | $51.3M | $44.1M | $51.9M | $57.6M | $38.2M | $59.9M | $59.3M | $57.5M | $58.8M | $58.7M | $56.4M | $44.1M |
| Gross Profit | $54.8M | $66.1M | $60.8M | $67.7M | $58.0M | $64.3M | $63.2M | $39.2M | $48.7M | $49.3M | $47.7M | $52.3M | $50.2M | $51.8M | $41.7M |
| SG&A Expense | $21.5M | $22.8M | $24.5M | $24.3M | $23.5M | $22.8M | $21.4M | $17.5M | $19.8M | $16.8M | $17.9M | $18.1M | $17.6M | $17.7M | $15.1M |
| R&D Expense | $10.4M | $11.8M | $12.3M | $10.8M | $8.7M | $10.7M | $11.0M | $5.6M | $6.4M | $4.9M | $4.2M | $4.3M | $3.9M | $4.7M | $4.4M |
| Operating Income | -$6.2M | $1.9M | -$6.9M | $2.1M | $221.0K | $377.0K | $984.0K | -$635.0K | -$1.7M | $6.6M | $1.5M | $7.8M | $8.4M | $10.2M | $8.1M |
| Interest Expense | $3.2M | - | - | - | - | - | - | $713.0K | $846.0K | $990.0K | $955.0K | $584.0K | $752.0K | $677.0K | $277.0K |
| Income Tax | $740.0K | $859.0K | $337.0K | $148.0K | $518.0K | -$815.0K | -$3.7M | -$605.0K | $15.4M | $2.1M | -$288.0K | $2.4M | $1.6M | -$9.5M | $2.7M |
| Net Income | -$12.4M | -$3.4M | -$9.5M | -$288.0K | -$7.8M | -$4.7M | -$2.9M | -$865.0K | -$19.0M | $2.4M | -$1.8M | $2.4M | $3.8M | $19.0M | $7.2M |
| EPS (Basic) | -$0.28 | -$0.08 | -$0.23 | -$0.01 | - | - | -$0.08 | -$0.02 | -$0.57 | $0.07 | -$0.06 | $0.09 | $0.14 | $0.66 | $0.24 |
| EPS (Diluted) | -$0.28 | -$0.08 | -$0.23 | - | -$0.20 | -$0.12 | -$0.08 | -$0.02 | -$0.57 | $0.07 | -$0.06 | $0.08 | $0.13 | $0.65 | $0.24 |
| Shares Outstanding | 44.1M | 43.4M | 42.1M | 41.1M | 39.4M | 38.2M | 37.4M | 35.0M | 34.4M | 34.0M | 32.6M | 31.6M | 29.4M | 28.5M | 28.3M |
| Gross Margin | 58.2% | 58.9% | 53.7% | 56.9% | 56.9% | 55.4% | 52.3% | 50.6% | 44.8% | 45.4% | 45.4% | 47.1% | 46.1% | 47.9% | 48.6% |
| Operating Margin | -6.6% | 1.7% | -6.1% | 1.7% | 0.2% | 0.3% | 0.8% | -0.8% | -1.6% | 6.1% | 1.5% | 7.0% | 7.7% | 9.4% | 9.4% |
| Profit Margin | -13.2% | -3.0% | -8.4% | -0.2% | -7.6% | -4.0% | -2.4% | -1.1% | -17.5% | 2.2% | -1.7% | 2.1% | 3.5% | 17.6% | 8.4% |